This designation is intended to spark innovation among biotech companies that are developing treatments for these patient populations, which by definition affect fewer than 200,000 people in the U.S., by providing incentives such as tax credits, user-fee exemptions and up to seven years of market...
Stereotactic radiosurgery was described according to a consensus definition,23 and all platforms of SRS delivery were acceptable. After undergoing SRS, patients underwent follow up with clinical and radiographic surveillance per institutional standards. Data were collected on treatment center, treatment year...